Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Jun 2024 for Deciphera Pharmaceuticals, Inc..
Filing timeline
BuySaleDennis Leo Walsh
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Dennis Leo Walsh: trading record in brief
Dennis Leo Walsh discloses dealings in Deciphera Pharmaceuticals, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 10 May 2023 to 11 June 2024.
Purchases make up the whole of the open-market record (1 purchase, €139k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 11 June 2024 came the latest disclosure, a transaction in Deciphera Pharmaceuticals, Inc. The last purchase on record was published on 12 May 2023, which is 1,261 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Dennis Leo Walsh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
11,000 sharesCommon StockSEC:0000950170-24-072208:0
11,000 shares@ US$13.856100.0% of flowCommon StockSEC:0001209191-23-028989:0
Canonical exit: 8 Aug 2023 (T+90)
2 of 2 declarations
